Close Menu
    What's Hot

    New Research Suggests That Communication Through the Buy-Out Process Is a Critical Enabler of a Smooth Transition

    February 5, 2026

    Bibby Line Group Limited Pension Scheme Completes Bulk Purchase Annuity Buy-In With PIC

    February 5, 2026

    UK Pension Risk Transfer Market Surpasses £500bn of Transactions

    February 2, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Tailwinds and Structural Strength Support Sustainable — If Moderating — US Life & Annuity Market Growth

      November 12, 2025

      US Annuity Sales Set Yet Another Quarterly Sales Record in Third Quarter of 2025

      October 30, 2025

      10 Areas To Watch for AI Innovation in Life and Health Underwriting and Claims

      January 28, 2026

      Lewis & Ellis and Griffith, Ballard & Company Expand Life Insurance Capabilities Through Strategic Partnership

      January 21, 2026

      Stability Continues in US Life Insurer Ownership and Solvency Metrics

      January 14, 2026

      Third Quarter Sets New US Annuity Sales Record

      December 10, 2025

      New Research Suggests That Communication Through the Buy-Out Process Is a Critical Enabler of a Smooth Transition

      February 5, 2026

      Bibby Line Group Limited Pension Scheme Completes Bulk Purchase Annuity Buy-In With PIC

      February 5, 2026

      UK Pension Risk Transfer Market Surpasses £500bn of Transactions

      February 2, 2026

      Royal Star & Garter Pension Scheme Completes Bulk Purchase Annuity Buy-In With Just Group

      February 2, 2026

      CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

      January 14, 2026

      Still Hot and Bothered?

      December 22, 2025

      Decoding Progress: The Evolution of Life Expectancy for Cancer Patients

      November 26, 2025

      Q&A: James Hadley, Senior Consultant, Barnett Waddingham

      November 26, 2025

      UK Equity Release Market Sees Double-Digit Growth in 2025

      January 28, 2026

      Equity Release Missing From Retirement Planning Conversations

      January 22, 2026

      Equity Release Council Promotes Kelly Melville-Kelly to Deputy CEO

      January 22, 2026

      AIR Asset Management’s Taylor Garvey Joins LISA Board, Promoted to Managing Director

      January 19, 2026

      New Research Suggests That Communication Through the Buy-Out Process Is a Critical Enabler of a Smooth Transition

      February 5, 2026

      Bibby Line Group Limited Pension Scheme Completes Bulk Purchase Annuity Buy-In With PIC

      February 5, 2026

      UK Pension Risk Transfer Market Surpasses £500bn of Transactions

      February 2, 2026

      Royal Star & Garter Pension Scheme Completes Bulk Purchase Annuity Buy-In With Just Group

      February 2, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026

      Editor’s Letter – Volume 1, Issue 3, December 2025

      December 10, 2025

      Editor’s Letter – Volume 1, Issue 2, November 2025

      November 12, 2025

      Editor’s Letter – Volume 1, Issue 1, October 2025

      October 8, 2025

      Editor’s Letter – Volume 4, Issue 9, September 2025

      September 10, 2025
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Despite Bumpy Couple of Years, Lessons Learned Stand Life ILS Market in Good Stead

    Life Insurance Capital Solutions February 14, 2024By Greg Winterton
    Share
    Twitter LinkedIn Email

    The alternative credit industry experienced something of an up-and-down year in 2023. On one hand, fundraising pulled back as investors rotated into more liquid, higher yielding credit investments, and on the other, existing funds, particularly in the private debt space, with floating rate loans enjoyed higher returns. 

    The impact of higher interest rates was certainly felt keenly in the life ILS corner of the alternative credit space last year, in both capital raising and deal activity. In the former, the reasons were consistent with the alternative credit market at large.  

    But in deal flow, certain trades experienced a retraction in activity. One example is value in force (VIF) deals, a transaction where asset managers pay a discounted upfront cash sum to an insurer in return for the payment stream of a block of insurance policies. 

    “The rise in interest rates in conjunction with a widening of risk spreads has led to higher absolute costs of financing which has presented challenges to investment counterparties. That higher cost of financing has an impact on the appetite for certain VIF structures because sellers and suppliers of risk are having to pay more than in the past. Some counterparties are questioning whether or not they’re comfortable printing at the top of the cycle,” says Craig Gillespie, Head of Life and Alternative Credit at investment manager, Leadenhall Capital Partners. 

    But whilst there may be a contraction in the supply of VIF transactions, higher rates are providing an opportunity for managers in the space to be more selective with regards to the deals that they do underwrite. 

    “Insurance businesses that still have a need for capital or liquidity have had to pay up the increased all in rates of financing. There’s been something of a flight to quality, where we’ve focused on working selectively with the best counterparties and pipeline opportunities in the market – there’s the opportunity to earn an increased spread whilst taking less risk than in recent periods. We’re being more prescriptive in terms of where we allocate capital,” added Gillespie. 

    In January, the US Federal Reserve kept its Federal Funds Rate flat for the fourth consecutive time, and the European Central Bank’s three main interest rates also remained constant. The UK’s Bank of England hasn’t increased its Base Rate since last August. Couple this with falling inflation adds up to encouragement in consumer and political circles that the recent rising interest rate regime has plateaued. But, even if markets are now at the top of the interest rate cycle, and at some point this year, interest rates began to fall, the floodgates won’t necessarily re-open. 

    That’s because both the Covid-19 pandemic and the recent macroeconomic environment have had something of a longer-term impact on the life ILS market, conspiring together to force investors in the market to re-evaluate certain aspects of their deal origination function. 

    “Covid underlined the fact that, from an actuarial perspective, populations are not created equally. During the pandemic, certain socio-economic groups were impacted by excess mortality more than others. General population mortality-based investment structures haven’t fared very well in the past few years, which means that our underwriting efforts are being further refined according to the underlying population exposure,” says Gillespie. 

    Recent macroeconomic events and the stronger volatility and uncertainty have also had an impact on how insurance companies approach capital solutions. 

    “In general, we see a strong increase in derisking and capital management activity in the European life insurance landscape. The bulk of the risk goes to the reinsurance industry but clearly Life ILS can play an increasingly relevant role moving forward. Whereas in the past the role of Life ILS was predominantly on the financing front, the end investors often now require ILS managers to revert to more biometric risk-driven investments or, ‘back to basics’ as they like to say,” says Luca Tres, Head of Strategic Risk and Capital Life Solutions, EMEA at insurance consulting firm, Guy Carpenter. 

    However, there is still, and will always be, appetite for financing solutions from the life insurance segment. 

    “Sitting in-between capital markets and the life (re)insurance industry, the Life ILS market introduces a differentiated capacity in the financing space, specifically for opportunities with a strong biometrical or lapse component. Therefore, it is clear that Life ILS will continue to be a strategic partner for the life (re)insurance industry”, adds Tres.  

    There’s a saying in the family office space that when you’ve met one family office, you’ve met one family office. The same could be said for the life ILS industry; not all asset managers enter into the same types of transactions, leading to less homogeneity within the space when compared to, say, the non-life ILS catastrophe bond market. The complexity of insurance-linked transactions when compared to other alternative credit strategies means that investor education is ongoing, and macroeconomic cyclicality has impacted the space like it has many private markets strategies.  

    But for Gillespie, the lessons of the past few years will prove beneficial in the medium to longer term, and overall, the message to investors remains. 

    “The life ILS space has actually been around for many years, but for the first 10, it was a relatively benign market. We’ve had two major tests in the last five years that have put certain investment structures to the test. These tests have helped the life ILS market to understand where the true risk premiums should lie, and whether these are aligned to the actual losses that could materialise when an event happens,” he says. 

    “This development in itself hasn’t changed the investment case for life ILS. The demand from life insurers and other life-linked insurance businesses for financing solutions is there. The supply of capital is there because investors need and want medium to long-dated exposures that offer differentiated risk-return profiles to the main capital markets. If anything, the events of the past few years have served to strengthen the offering by making the investment processes that underpin it more robust.” 

    2024 - February Life ILS Volume 3 Issue 2 - February 2024
    Share. Twitter LinkedIn Email

    Related Posts

    Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

    November 26, 2025By Greg Winterton

    Is It Time to Rate Life ILS Structures?

    October 22, 2025By Greg Winterton

    Q&A: Chris Wells, Managing Editor, Longevity and Mortality Investor

    October 8, 2025By Greg Winterton

    HSCM Bermuda Closes Secondaries Fund to Acquire Life Insurance-Linked Securities Portfolio

    September 25, 2025By LMI Newsdesk
    Latest Issue

    Busy December in PHL Variable Life Insurance Company Saga but Is the End Now in Sight?

    January 14, 2026

    Will 2026 Be the Year That the US Agency-Backed Reverse Mortgage Market Finally Gets Its Well-Overdue Reform?

    January 14, 2026

    CMI Model Changes and Weight-Loss Drug Popularity Point to Changed Mortality Picture

    January 14, 2026

    Stability Continues in US Life Insurer Ownership and Solvency Metrics

    January 14, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.